Swiss National Bank’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Hold
39,100
﹤0.01% 2198
2025
Q4
$537K Hold
39,100
﹤0.01% 2284
2025
Q3
$692K Buy
39,100
+7,000
+22% +$111K ﹤0.01% 2261
2025
Q2
$484K Buy
32,100
+8,300
+35% +$138K ﹤0.01% 2310
2025
Q1
$383K Sell
23,800
-12,100
-34% -$226K ﹤0.01% 2374
2024
Q4
$625K Hold
35,900
﹤0.01% 2359
2024
Q3
$630K Buy
+35,900
New +$612K ﹤0.01% 2376

Other funds holding PLSE

Swiss National Bank's PLSE Position: Q1 2026 in Review

Swiss National Bank held its Pulse Biosciences (PLSE) position steady in Q1 2026 at 39,100 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Swiss National Bank first reported a position in PLSE in Q3 2024 and has held it in 7 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Swiss National Bank held 39,100 shares of Pulse Biosciences worth $844K as of Q1 2026.
  • Swiss National Bank left its Pulse Biosciences share count unchanged in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2198 holding.
  • Swiss National Bank first reported a position in Pulse Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.